| Literature DB >> 26894958 |
Claudia Scheckel1,2, Elodie Drapeau3,4, Maria A Frias1,2, Christopher Y Park1,2,5, John Fak1,2, Ilana Zucker-Scharff1,2, Yan Kou3,6, Vahram Haroutunian4,7,8, Avi Ma'ayan6, Joseph D Buxbaum3,4,9,10,11, Robert B Darnell1,2,5.
Abstract
Neuronal ELAV-like (nELAVL) RNA binding proteins have been linked to numerous neurological disorders. We performed crosslinking-immunoprecipitation and RNAseq on human brain, and identified nELAVL binding sites on 8681 transcripts. Using knockout mice and RNAi in human neuroblastoma cells, we showed that nELAVL intronic and 3' UTR binding regulates human RNA splicing and abundance. We validated hundreds of nELAVL targets among which were important neuronal and disease-associated transcripts, including Alzheimer's disease (AD) transcripts. We therefore investigated RNA regulation in AD brain, and observed differential splicing of 150 transcripts, which in some cases correlated with differential nELAVL binding. Unexpectedly, the most significant change of nELAVL binding was evident on non-coding Y RNAs. nELAVL/Y RNA complexes were specifically remodeled in AD and after acute UV stress in neuroblastoma cells. We propose that the increased nELAVL/Y RNA association during stress may lead to nELAVL sequestration, redistribution of nELAVL target binding, and altered neuronal RNA splicing.Entities:
Keywords: Y RNA; alternative splicing; alzheimer's disease; biochemistry; human; imr-32 cells; mRNA stability; mouse; nELAVL; neuronal RNA binding protein; neuroscience; noncoding RNA
Mesh:
Substances:
Year: 2016 PMID: 26894958 PMCID: PMC4798961 DOI: 10.7554/eLife.10421
Source DB: PubMed Journal: Elife ISSN: 2050-084X Impact factor: 8.140